
Commercial Leadership Development Associate
AstraZeneca
Summary
The Rare Disease Unit Commercial Leadership Development Associate supports the development and execution of commercial initiatives that enhance the value and impact of Alexion, AstraZeneca Rare Disease's portfolio.
Job description
This three-year rotational program is designed to accelerate career development through hands-on experience, cross-functional exposure, and meaningful networking opportunities. Associates complete three 12-month rotations, each aligned with a critical business challenge and a core commercial function, including Marketing, Market Access, Business Operations, Strategy, Sales, and Finance.
Through these experiences, you'll gain a broad understanding of the U.S. rare disease business while developing the strategic thinking, leadership, and management needed to succeed in the pharmaceutical industry.
What you'll do
The candidate will work as an integrated member of Alexion's U.S. Commercial organization from day one through role-based rotations. Depending on the assigned role and business needs, candidates may contribute across different functions including but not limited to:
- Marketing: Positioning, messaging, campaign development, launch/lifecycle planning, brand planning, opportunity assessments, etc.
- Market Access: Payer marketing, access strategy, channel leadership, contracting strategy, etc.
- Business Operations: Data strategy, business analytics, field force sizing and incentives, expansion of omnichannel and digital transformation strategies, etc.
Essential Skills/Experience
- MBA graduation dates: Winter 2026 or Spring/Summer 2027
- Proven academic achievement
- 2-6 years of work experience prior to MBA - preferably within pharma/biotech
- Must work on-site in the Boston Seaport office
- Excellent written and oral communication skills
- Outstanding work ethic
- Agility/Leadership Potential
Desirable Skills/Experience
- Pharmaceutical and multi-industry experience is strongly preferred.
- Ability to adapt to evolving business needs.
- Understanding of the market access landscape and experience with secondary analysis.
- Analytical skills including data reporting, analysis, problem-solving, forecasting, and financial modeling.
Requirements
- MBA graduation dates: Winter 2026 or Spring/Summer 2027
- Proven academic achievement
- 2-6 years of work experience prior to MBA - preferably within pharma/biotech
- Must work on-site in the Boston Seaport office
- Excellent written and oral communication skills
- Outstanding work ethic
- Agility/Leadership Potential
- Pharmaceutical and multi-industry experience is strongly preferred
- Ability to adapt to evolving business needs
- Understanding of the market access landscape and experience with secondary analysis
- Analytical skills including data reporting, analysis, problem-solving, forecasting, and financial modeling
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.